Literature DB >> 28181432

Mimicking Hierarchical Complexity of the Osteochondral Interface Using Electrospun Silk-Bioactive Glass Composites.

Joseph Christakiran M1, Philip J T Reardon2, Rocktotpal Konwarh1, Jonathan C Knowles2, Biman B Mandal1.   

Abstract

The anatomical complexity and slow regeneration capacity of hyaline cartilage at the osteochondral interface pose a great challenge in the repair of osteochondral defects (OCD). In this study, we utilized the processing feasibility offered by the sol derived 70S bioactive glass and silk fibroin (mulberry Bombyx mori and endemic Indian non-mulberry Antheraea assama), in fabricating a well-integrated, biomimetic scaffolding matrix with a coherent interface. Differences in surface properties such as wettability and amorphousness between the two silk groups resulted in profound variations in cell attachment and extracellular matrix protein deposition. Mechanical assessment showed that the biphasic composites exhibited both an elastic region pertinent for cartilage tissue and a stiff compression resistant region simulating the bone phase. In vitro biological studies revealed that the biphasic mats presented spatial confinement for the growth and maturation of both osteoblasts and chondrocytes, marked by increased alkaline phosphatase (ALP) activity, osteopontin (OPN), sulfated glycosaminoglycan (sGAG) and collagen secretion in the cocultured mats. The non-mulberry silk based biphasic composite mats performed better than their mulberry counterpart, as evidenced by enhanced expression levels of key cartilage and bone specific marker genes. Therefore, the developed biphasic scaffold show great promise for improving the current clinical strategies for osteochondral tissue repair.

Entities:  

Keywords:  bioactive glass; biomaterials; nonmullberry silk; osteochondral tissue engineering; silk fibroin

Mesh:

Substances:

Year:  2017        PMID: 28181432     DOI: 10.1021/acsami.6b16590

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

Review 1.  Silk fibroin-based biomaterials for cartilage/osteochondral repair.

Authors:  Ziyang Zhou; Jin Cui; Shunli Wu; Zhen Geng; Jiacan Su
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

2.  Chitosan-Based Nanofibrous Membrane Unit with Gradient Compositional and Structural Features for Mimicking Calcified Layer in Osteochondral Matrix.

Authors:  Jiaoyan Liu; Qing Fang; Xiaofeng Yu; Ying Wan; Bo Xiao
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

3.  Therapeutically Effective Controlled Release Formulation of Pirfenidone from Nontoxic Biocompatible Carboxymethyl Pullulan-Poly(vinyl alcohol) Interpenetrating Polymer Networks.

Authors:  Saundray Raj Soni; Bibhas K Bhunia; Nimmy Kumari; Subhashis Dan; Sudipta Mukherjee; Biman B Mandal; Animesh Ghosh
Journal:  ACS Omega       Date:  2018-09-26

Review 4.  Advances and prospects in biomimetic multilayered scaffolds for articular cartilage regeneration.

Authors:  Liwei Fu; Zhen Yang; Cangjian Gao; Hao Li; Zhiguo Yuan; Fuxin Wang; Xiang Sui; Shuyun Liu; Quanyi Guo
Journal:  Regen Biomater       Date:  2020-09-30

Review 5.  Scaffold-Based Tissue Engineering Strategies for Osteochondral Repair.

Authors:  Jiang-Nan Fu; Xing Wang; Meng Yang; You-Rong Chen; Ji-Ying Zhang; Rong-Hui Deng; Zi-Ning Zhang; Jia-Kuo Yu; Fu-Zhen Yuan
Journal:  Front Bioeng Biotechnol       Date:  2022-01-11

6.  Repair of osteochondral defects mediated by double-layer scaffolds with natural osteochondral-biomimetic microenvironment and interface.

Authors:  Tao Wang; Wei Xu; Xintong Zhao; Baoshuai Bai; Yuejie Hua; Jincheng Tang; Feifan Chen; Yu Liu; Yahui Wang; Guangdong Zhou; Yilin Cao
Journal:  Mater Today Bio       Date:  2022-03-08

Review 7.  Biodegradable Inks in Indirect Three-Dimensional Bioprinting for Tissue Vascularization.

Authors:  Yiting Ze; Yanxi Li; Linyang Huang; Yixin Shi; Peiran Li; Ping Gong; Jie Lin; Yang Yao
Journal:  Front Bioeng Biotechnol       Date:  2022-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.